SOD1 and rheumatoid arthritis: The inflammatory cell-mediated overproduction of TNF-α is thought to be the main contributor to the increased release of ROS in RA patients [40], because TNF-α not only causes cell damage but also inhibits antioxidants, such as superoxide dismutase 1 (SOD1) and SOD3 [41, 42].